Clincosm LogoSign in Get a demo

Stage IV Breast Cancer AJCC v6 and v7

Showing 26 - 40 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IV Breast Cancer AJCC v6 and v7 Trial in Columbus (dietary supplement, other, drug)

Completed
  • Stage IV Breast Cancer AJCC v6 and v7
  • Dietary Intervention
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 7, 2021

Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in Seattle (procedure, drug,

Terminated
Has Results
  • Estrogen Receptor Positive
  • +2 more
  • Computed Tomography
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 28, 2021

Advanced Malignant Solid Tumor, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (drug, other, biological)

Completed
  • Advanced Malignant Solid Neoplasm
  • +12 more
  • Houston, Texas
  • +4 more
Dec 16, 2020

Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7 Trial in United States

Unknown status
  • Metastatic Breast Carcinoma
  • +3 more
  • Farmington, Connecticut
  • +20 more
Aug 14, 2020

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7 Trial in United States (drug,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +4 more
  • Mobile, Alabama
  • +389 more
Mar 11, 2020

Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in Chicago, Saint Louis

Completed
Has Results
  • Recurrent Breast Carcinoma
  • +5 more
  • Chicago, Illinois
  • +1 more
Feb 13, 2020

Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (Fulvestrant, Laboratory

Completed
Has Results
  • Estrogen Receptor Positive
  • +7 more
  • Little Rock, Arkansas
  • +367 more
Dec 9, 2019

HER2/Neu Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma Trial in Houston (drug, other, biological)

Completed
  • HER2/Neu Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 17, 2019

Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive Trial (Copanlisib, Fulvestrant, Laboratory

Withdrawn
  • Estrogen Receptor Positive
  • +3 more
  • (no location specified)
Aug 13, 2018

Estrogen Receptor Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma Trial in Saint Louis (Akt Inhibitor MK2206,

Completed
  • Estrogen Receptor Positive
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 20, 2018

Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)

Withdrawn
  • Advanced Malignant Solid Neoplasm
  • +17 more
  • Glembatumumab Vedotin
  • +4 more
  • (no location specified)
Jul 17, 2018

Male Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (biological,

Completed
Has Results
  • Male Breast Carcinoma
  • +2 more
  • Cixutumumab
  • +3 more
  • Palo Alto, California
  • +191 more
May 15, 2018

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Estrogen Receptor Negative Trial in Bronx, Columbus (drug, other, procedure)

Completed
  • BRCA1 Gene Mutation
  • +11 more
  • Bronx, New York
  • +2 more
Apr 20, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Houston (Dinaciclib, Epirubicin Hydrochloride,

Completed
  • Estrogen Receptor Negative
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 29, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Bronx, New York (Laboratory Biomarker Analysis,

Completed
  • Estrogen Receptor Negative
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Bronx, New York
  • +5 more
Dec 21, 2017